skeleton
| N |
• mice exhibit normal osteoblast parameters
|
|
• mice exhibit decreased osteoclast number and size compared with Tyrobptm1Ttk homozygotes
|
|
• TGFB1-treated bone marrow macrophage immobilized on a minimal hOSCAR-binding triple-helical peptide (OSCpep) fail to exhibit an increate in giant TRAP+ osteoclasts unlike similarly treated cells from Tyrobptm1Ttk homozygotes
|
|
• compared with Tyrobptm1Ttk homozygotes
|
|
• mice exhibit a reduction in eroded bone surface compared with Tyrobptm1Ttk homozygotes
|
|
• mice exhibit increased bone trabecula number, increased trabecular bone volume, and decreased trabecular space compared with Tyrobptm1Ttk homozygotes
|
|
• compared with Tyrobptm1Ttk homozygotes
|
|
• compared with Tyrobptm1Ttk homozygotes
|
cellular
|
• TGFB1-treated bone marrow macrophage immobilized on a minimal hOSCAR-binding triple-helical peptide (OSCpep) fail to exhibit an increate in giant TRAP+ osteoclasts unlike similarly treated cells from Tyrobptm1Ttk homozygotes
|
hematopoietic system
|
• mice exhibit decreased osteoclast number and size compared with Tyrobptm1Ttk homozygotes
|
|
• TGFB1-treated bone marrow macrophage immobilized on a minimal hOSCAR-binding triple-helical peptide (OSCpep) fail to exhibit an increate in giant TRAP+ osteoclasts unlike similarly treated cells from Tyrobptm1Ttk homozygotes
|
|
• compared with Tyrobptm1Ttk homozygotes
|
|
• mice exhibit a reduction in eroded bone surface compared with Tyrobptm1Ttk homozygotes
|
immune system
|
• mice exhibit decreased osteoclast number and size compared with Tyrobptm1Ttk homozygotes
|
|
• TGFB1-treated bone marrow macrophage immobilized on a minimal hOSCAR-binding triple-helical peptide (OSCpep) fail to exhibit an increate in giant TRAP+ osteoclasts unlike similarly treated cells from Tyrobptm1Ttk homozygotes
|
|
• compared with Tyrobptm1Ttk homozygotes
|
|
• mice exhibit a reduction in eroded bone surface compared with Tyrobptm1Ttk homozygotes
|


Analysis Tools